Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Gene Knockdown Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gene Knockdown Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Gene Knockdown Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 siRNA
    • 1.4.3 shRNA
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Gene Knockdown Market Share by Application: 2020 VS 2026
    • 1.5.2 Medical
    • 1.5.3 Bioengineering
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Gene Knockdown Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Gene Knockdown Industry
      • 1.6.1.1 Gene Knockdown Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Gene Knockdown Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Gene Knockdown Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Gene Knockdown Market Perspective (2015-2026)
  • 2.2 Gene Knockdown Growth Trends by Regions
    • 2.2.1 Gene Knockdown Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gene Knockdown Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gene Knockdown Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Gene Knockdown Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Gene Knockdown Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Knockdown Players by Market Size
    • 3.1.1 Global Top Gene Knockdown Players by Revenue (2015-2020)
    • 3.1.2 Global Gene Knockdown Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Gene Knockdown Market Concentration Ratio
    • 3.2.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2019
  • 3.3 Gene Knockdown Key Players Head office and Area Served
  • 3.4 Key Players Gene Knockdown Product Solution and Service
  • 3.5 Date of Enter into Gene Knockdown Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Gene Knockdown Historic Market Size by Type (2015-2020)
  • 4.2 Global Gene Knockdown Forecasted Market Size by Type (2021-2026)

5 Gene Knockdown Breakdown Data by Application (2015-2026)

  • 5.1 Global Gene Knockdown Market Size by Application (2015-2020)
  • 5.2 Global Gene Knockdown Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gene Knockdown Market Size (2015-2020)
  • 6.2 Gene Knockdown Key Players in North America (2019-2020)
  • 6.3 North America Gene Knockdown Market Size by Type (2015-2020)
  • 6.4 North America Gene Knockdown Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Gene Knockdown Market Size (2015-2020)
  • 7.2 Gene Knockdown Key Players in Europe (2019-2020)
  • 7.3 Europe Gene Knockdown Market Size by Type (2015-2020)
  • 7.4 Europe Gene Knockdown Market Size by Application (2015-2020)

8 China

  • 8.1 China Gene Knockdown Market Size (2015-2020)
  • 8.2 Gene Knockdown Key Players in China (2019-2020)
  • 8.3 China Gene Knockdown Market Size by Type (2015-2020)
  • 8.4 China Gene Knockdown Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Gene Knockdown Market Size (2015-2020)
  • 9.2 Gene Knockdown Key Players in Japan (2019-2020)
  • 9.3 Japan Gene Knockdown Market Size by Type (2015-2020)
  • 9.4 Japan Gene Knockdown Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Gene Knockdown Market Size (2015-2020)
  • 10.2 Gene Knockdown Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Gene Knockdown Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Gene Knockdown Market Size by Application (2015-2020)

11 India

  • 11.1 India Gene Knockdown Market Size (2015-2020)
  • 11.2 Gene Knockdown Key Players in India (2019-2020)
  • 11.3 India Gene Knockdown Market Size by Type (2015-2020)
  • 11.4 India Gene Knockdown Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Gene Knockdown Market Size (2015-2020)
  • 12.2 Gene Knockdown Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Gene Knockdown Market Size by Type (2015-2020)
  • 12.4 Central & South America Gene Knockdown Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Santa Cruz Biotechnology (US)
    • 13.1.1 Santa Cruz Biotechnology (US) Company Details
    • 13.1.2 Santa Cruz Biotechnology (US) Business Overview and Its Total Revenue
    • 13.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
    • 13.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2015-2020))
    • 13.1.5 Santa Cruz Biotechnology (US) Recent Development
  • 13.2 OriGene (US)
    • 13.2.1 OriGene (US) Company Details
    • 13.2.2 OriGene (US) Business Overview and Its Total Revenue
    • 13.2.3 OriGene (US) Gene Knockdown Introduction
    • 13.2.4 OriGene (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.2.5 OriGene (US) Recent Development
  • 13.3 Sigma-Aldrich (US)
    • 13.3.1 Sigma-Aldrich (US) Company Details
    • 13.3.2 Sigma-Aldrich (US) Business Overview and Its Total Revenue
    • 13.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
    • 13.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.3.5 Sigma-Aldrich (US) Recent Development
  • 13.4 Abnova (Taiwan)
    • 13.4.1 Abnova (Taiwan) Company Details
    • 13.4.2 Abnova (Taiwan) Business Overview and Its Total Revenue
    • 13.4.3 Abnova (Taiwan) Gene Knockdown Introduction
    • 13.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2015-2020)
    • 13.4.5 Abnova (Taiwan) Recent Development
  • 13.5 Agilent Technologies (US)
    • 13.5.1 Agilent Technologies (US) Company Details
    • 13.5.2 Agilent Technologies (US) Business Overview and Its Total Revenue
    • 13.5.3 Agilent Technologies (US) Gene Knockdown Introduction
    • 13.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.5.5 Agilent Technologies (US) Recent Development
  • 13.6 Bio-Rad (US)
    • 13.6.1 Bio-Rad (US) Company Details
    • 13.6.2 Bio-Rad (US) Business Overview and Its Total Revenue
    • 13.6.3 Bio-Rad (US) Gene Knockdown Introduction
    • 13.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.6.5 Bio-Rad (US) Recent Development
  • 13.7 Cell Signaling Technology (US)
    • 13.7.1 Cell Signaling Technology (US) Company Details
    • 13.7.2 Cell Signaling Technology (US) Business Overview and Its Total Revenue
    • 13.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
    • 13.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.7.5 Cell Signaling Technology (US) Recent Development
  • 13.8 GeneCopoeia (US)
    • 13.8.1 GeneCopoeia (US) Company Details
    • 13.8.2 GeneCopoeia (US) Business Overview and Its Total Revenue
    • 13.8.3 GeneCopoeia (US) Gene Knockdown Introduction
    • 13.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.8.5 GeneCopoeia (US) Recent Development
  • 13.9 siTOOLs Biotech (Germany)
    • 13.9.1 siTOOLs Biotech (Germany) Company Details
    • 13.9.2 siTOOLs Biotech (Germany) Business Overview and Its Total Revenue
    • 13.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
    • 13.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2015-2020)
    • 13.9.5 siTOOLs Biotech (Germany) Recent Development
  • 13.10 Novus Biologicals (US)
    • 13.10.1 Novus Biologicals (US) Company Details
    • 13.10.2 Novus Biologicals (US) Business Overview and Its Total Revenue
    • 13.10.3 Novus Biologicals (US) Gene Knockdown Introduction
    • 13.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2015-2020)
    • 13.10.5 Novus Biologicals (US) Recent Development
  • 13.11 EMD Millipore (US)
    • 10.11.1 EMD Millipore (US) Company Details
    • 10.11.2 EMD Millipore (US) Business Overview and Its Total Revenue
    • 10.11.3 EMD Millipore (US) Gene Knockdown Introduction
    • 10.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.11.5 EMD Millipore (US) Recent Development
  • 13.12 BioVision (US)
    • 10.12.1 BioVision (US) Company Details
    • 10.12.2 BioVision (US) Business Overview and Its Total Revenue
    • 10.12.3 BioVision (US) Gene Knockdown Introduction
    • 10.12.4 BioVision (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.12.5 BioVision (US) Recent Development
  • 13.13 Creative Biomart (US)
    • 10.13.1 Creative Biomart (US) Company Details
    • 10.13.2 Creative Biomart (US) Business Overview and Its Total Revenue
    • 10.13.3 Creative Biomart (US) Gene Knockdown Introduction
    • 10.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.13.5 Creative Biomart (US) Recent Development
  • 13.14 Selleck Chemicals (US)
    • 10.14.1 Selleck Chemicals (US) Company Details
    • 10.14.2 Selleck Chemicals (US) Business Overview and Its Total Revenue
    • 10.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
    • 10.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.14.5 Selleck Chemicals (US) Recent Development
  • 13.15 MyBioSource (US)
    • 10.15.1 MyBioSource (US) Company Details
    • 10.15.2 MyBioSource (US) Business Overview and Its Total Revenue
    • 10.15.3 MyBioSource (US) Gene Knockdown Introduction
    • 10.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.15.5 MyBioSource (US) Recent Development
  • 13.16 Invitrogen (US)
    • 10.16.1 Invitrogen (US) Company Details
    • 10.16.2 Invitrogen (US) Business Overview and Its Total Revenue
    • 10.16.3 Invitrogen (US) Gene Knockdown Introduction
    • 10.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2015-2020)
    • 10.16.5 Invitrogen (US) Recent Development
  • 13.17 Qiagen (Germany)
    • 10.17.1 Qiagen (Germany) Company Details
    • 10.17.2 Qiagen (Germany) Business Overview and Its Total Revenue
    • 10.17.3 Qiagen (Germany) Gene Knockdown Introduction
    • 10.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2015-2020)
    • 10.17.5 Qiagen (Germany) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Gene Knockdown status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Knockdown development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Santa Cruz Biotechnology (US)
    OriGene (US)
    Sigma-Aldrich (US)
    Abnova (Taiwan)
    Agilent Technologies (US)
    Bio-Rad (US)
    Cell Signaling Technology (US)
    GeneCopoeia (US)
    siTOOLs Biotech (Germany)
    Novus Biologicals (US)
    EMD Millipore (US)
    BioVision (US)
    Creative Biomart (US)
    Selleck Chemicals (US)
    MyBioSource (US)
    Invitrogen (US)
    Qiagen (Germany)

    Market segment by Type, the product can be split into
    siRNA
    shRNA
    Other
    Market segment by Application, split into
    Medical
    Bioengineering
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Gene Knockdown status, future forecast, growth opportunity, key market and key players.
    To present the Gene Knockdown development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Gene Knockdown are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now